Overall Survival Benefits for Combining Targeted Therapy as Second-Line Treatment for Advanced Non-Small-Cell-Lung Cancer: A Meta-Analysis of Published Data

BACKGROUND: Combining targeted therapy has been extensively investigated in previously treated advanced non-small-cell lung cancer (NSCLC), but it is still unclear whether combining targeted therapy might offer any benefits against standard monotherapy with erlotinib. We thus performed a meta-analys...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Qi, Wei-Xiang, Wang, Qiong, Jiang, Yan-Ling, Sun, Yuan-Jue, Tang, Li-na, He, Ai-na, Min, Da-liu, Lin, Feng, Shen, Zan, Yao, Yang
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2013
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3568141/
https://ncbi.nlm.nih.gov/pubmed/23409011
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0055637
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados